查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1933362

全球家禽疫苗市場：市場規模、佔有率、成長率、產業分析、類型、應用及區域分析、未來預測（2026-2034）

Poultry Vaccines Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 167 Pages | 商品交期: 請詢問到貨日

價格

家禽疫苗市場成長因素

預計2025年全球家禽疫苗市場規模將達13.2億美元，2026年將達13.8億美元。預計到2034年將成長至23.8億美元，預測期內複合年增長率（CAGR）為6.99%。主要成長因素包括家禽產品需求的成長、禽流感、新城疫和傳染性支氣管炎等家禽傳染病發病率的上升，以及家禽養殖戶生物安全和疾病預防意識的提高。 到2025年，北美將以46.11%的市場佔有率主導市場，這得益於嚴格的監管、完善的家禽醫療保健基礎設施以及主要疫苗生產商的存在。諸如碩騰服務有限公司（Zoetis Services LLC）、默克公司（Merck & Co., Inc.）和勃林格殷格翰國際有限公司（Boehringer Ingelheim International GmbH）等領先企業憑藉其豐富的產品組合和廣泛的地域覆蓋，已確立了穩固的市場地位。

市場動態

驅動因素：家禽疫苗市場最重要的驅動因素是全球禽肉和禽蛋消費量的成長。隨著人口的增長，對動物性蛋白質的需求也在增加，因此家禽健康管理對於維護食品安全和營養品質至關重要。疫苗接種可以抑制疾病爆發，防止經濟損失，並確保家禽產品的穩定供應。 例如，根據美國農業部的數據，2024/2025年度美國雞肉產量將達到2,134萬噸，約佔全球產量的21%，凸顯了無病家禽群的重要性。

限制因素：疫苗失效和 "疫苗外洩" 是重大的市場挑戰。像馬立克氏症和禽流感這樣快速變異的疾病會降低疫苗的有效性，即使在接種過疫苗的家禽群中，死亡率也可能達到10%至40%。這些失效會促使經濟損失、生產者不滿以及疫苗推廣的延遲。

機會：政府主導的疫苗接種活動提供了成長機會。例如，2025年4月，印度畜牧和乳業部與家禽業合作，提供高致病性禽流感（HPAI）疫苗。 這些努力確保了免疫力的一致性，限制了疾病的爆發，並為市場擴張提供了機會。

挑戰：供應鏈中斷和儲存問題仍然是重大障礙。家禽疫苗必須在 2–8°C 的溫度下儲存才能保持效力，但中低收入國家冷鏈基礎設施不足會促使疫苗降解、免疫反應降低和浪費增加。

市場趨勢

產業正朝著卵內接種的方向發展，即在孵化第 18 天將疫苗注射到雞蛋中。這種方法可以實現孵化前免疫，減少操作應激，並確保免疫覆蓋的一致性。 HIPRA 和其他公司已在歐洲推出了 "EVANOVO" 等卵內疫苗，體現了大規模家禽養殖作業自動化和效率提升的趨勢。

市場區隔分析

依技術分類：市場包括滅活疫苗、減毒活疫苗、重組疫苗等疫苗。滅活疫苗因其在預防疫情爆發方面的有效性以及對動物性蛋白質日益增長的需求而佔主導地位。例如，2025年2月，碩騰服務有限公司（Zoetis Services LLC）的H5N2禽流感疫苗獲得了美國農業部（USDA）的有條件批准。

依疾病類型分類：病毒性疾病疫苗佔最大的市場佔有率，用於應對禽流感、新城疫和馬立克氏症等威脅。 2024年11月，勃林格殷格翰在印度推出了這些病毒性疾病的三聯疫苗，推動了該細分市場的成長。

依給藥途徑分類：注射疫苗因其劑量精準且免疫反應強而成為主流。 例如，2024年3月，默克公司（Merck & Co.）的雞用肌注疫苗NOBILIS MULTRIVA REOm獲得歐洲批准。

依分銷管道：得益於政府支持的疫苗接種計劃和積極的獸醫服務，獸醫診所在分銷中發揮著主導作用。 2025年6月，南非透過獸醫管道啟動了針對高致病性禽流感（HPAI）的大規模疫苗接種運動。

區域展望

北美：在相關法規、主要產業參與者和強勁的研發投入的支持下，北美有望引領市場，到2025年市場規模將達到6.1億美元。 2025年4月，美國農業部承諾投入1億美元用於禽流感疫苗研究。

歐洲：受家禽產品需求成長和生物安全意識提高的推動，預計到2025年，歐洲市場規模將達到3.6億美元，年增長率為5.97%。

亞太地區：亞太地區仍是全球第三大市場，預計到2025年市場規模將達到1.7億美元，主要受家禽消費量成長和疫苗接種率提高的推動。

拉丁美洲美洲、中東和非洲：在政府為改善家禽衛生而採取的舉措推動下，預計市場將溫和增長，到 2025 年分別達到 1.1 億美元和 6000 萬美元。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢
  • 市場挑戰

第四章：關鍵考慮因素

  • 家禽疾病概述：依主要國家和地區劃分（2025 年）
  • 監理狀況：依主要國家及地區劃分（2025）
  • 家禽疾病疫苗接種概述
  • 主要公司新技術應用狀況
  • 主要產業趨勢（併購、合作等）

第五章 全球家禽疫苗市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依技術分類
    • 滅活​​疫苗
    • 減毒活疫苗
    • 重組疫苗
    • 其他
  • 市場分析、洞察與預測：依疾病類型分類
    • 病毒性疾病
      • 禽流感
      • 新城疫
      • 馬立克氏症
      • 其他
    • 細菌性疾病疾病
      • 沙門氏菌病
      • 支原體病
      • 其他
    • 寄生蟲病
  • 市場分析、洞察與預測：依給藥途徑
    • 腸外給藥
    • 鼻腔給藥
    • 其他
  • 市場分析、洞察與預測：依分銷管道
    • 獸醫院
    • 獸醫診所
    • 藥局
    • 其他
  • 市場分析、洞察與預測：依地區
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美家禽疫苗市場分析：洞察與預測 （2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲家禽疫苗市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪的納維亞
    • 歐洲其他地區

第八章 亞太地區家禽疫苗市場分析：洞察與預測（2021-2034）

  • 依國家/地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章：拉丁美洲家禽疫苗市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章：中東與非洲家禽疫苗市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會（GCC）國家
    • 南非
    • 中東其他地區非洲

第十一章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
  • Elanco
  • Boehringer Ingelheim International GmbH
  • Virbac
  • Merck &Co., Inc.
  • Zoetis Services LLC
  • Ceva
  • Bioveta, a.s.
  • Indian Immunologicals Ltd.
  • HIPRA
Product Code: FBI113875

Growth Factors of poultry vaccines Market

The global poultry vaccines market was valued at USD 1.32 billion in 2025 and is projected to reach USD 1.38 billion in 2026, eventually growing to USD 2.38 billion by 2034, reflecting a CAGR of 6.99% during the forecast period. The market is primarily driven by the rising demand for poultry products, increasing incidences of infectious poultry diseases such as avian influenza, Newcastle disease, and infectious bronchitis, and growing awareness about biosecurity and disease prevention among poultry farmers. North America dominated the market in 2025 with a 46.11% share, supported by stringent regulations, robust healthcare infrastructure for poultry, and the presence of leading vaccine manufacturers. Key players such as Zoetis Services LLC, Merck & Co., Inc., and Boehringer Ingelheim International GmbH hold strong market positions due to broad product portfolios and extensive geographic presence.

Market Dynamics

Drivers: The most significant driver of the poultry vaccines market is the increasing consumption of poultry meat and eggs globally. A growing population has led to higher demand for animal-based protein, making flock health critical to maintaining food security and nutritional quality. Vaccination reduces disease outbreaks, prevents economic losses, and ensures a steady supply of poultry products. For instance, as per the U.S. Department of Agriculture, 21.34 million metric tons of chicken meat were produced in the U.S. during 2024/2025, accounting for around 21% of global production, highlighting the importance of disease-free flocks.

Restraints: Vaccine failures and "leaky vaccines" pose significant market challenges. Rapidly mutating diseases like Marek's disease and avian influenza can reduce vaccine efficacy, causing flock mortality of 10-40% even in vaccinated populations. These failures result in economic losses, farmer dissatisfaction, and slowed adoption of vaccines.

Opportunities: Government vaccination campaigns offer growth potential. For example, in April 2025, India's Department of Animal Husbandry & Dairying collaborated with the poultry industry to offer vaccines against Highly Pathogenic Avian Influenza (HPAI). Such initiatives ensure uniform immunity coverage, mitigate disease outbreaks, and provide opportunities for market expansion.

Challenges: Supply chain disruptions and storage issues remain critical barriers. Poultry vaccines must be stored at 2-8°C to remain effective, and inadequate cold chain infrastructure in lower-middle-income countries can lead to degradation, poor immune responses, and higher wastage.

Market Trends

The industry is witnessing a shift toward in-ovo vaccination technology, where vaccines are injected into eggs on day 18 of incubation. This method offers immunity before hatching, reduces handling stress, and ensures uniform coverage. Companies like HIPRA have launched in-ovo vaccines such as EVANOVO in Europe, exemplifying this trend toward automation and efficiency in large-scale poultry operations.

Segmentation Analysis

By Technology: The market includes inactivated, live attenuated, recombinant, and other vaccines. Inactivated vaccines dominate due to their effectiveness in preventing outbreaks and growing demand for animal protein. For instance, in February 2025, Zoetis Services LLC received USDA conditional approval for its H5N2 Avian Influenza vaccine.

By Disease Type: Viral disease vaccines hold the largest market share, addressing threats from avian influenza, Newcastle disease, and Marek's disease. Boehringer Ingelheim launched a three-in-one vaccine in India (Nov 2024) for these viral diseases, boosting segment growth.

By Route of Administration: Parenteral vaccines dominate due to precise dosing and stronger immune responses. For example, in March 2024, Merck & Co., Inc. obtained European approval for NOBILIS MULTRIVA REOm for intramuscular use in chickens.

By Distribution Channel: Veterinary hospitals lead in distribution due to government-backed vaccination programs and proactive veterinary services. In June 2025, South Africa launched a mass HPAI vaccination campaign through veterinary channels.

Regional Outlook

North America: Dominates with a USD 0.61 billion market size in 2025, driven by regulations, key industry players, and strong R&D investments. The U.S. Department of Agriculture funded USD 100 million in April 2025 for avian influenza vaccine research.

Europe: Expected to reach USD 0.36 billion in 2025, growing at 5.97%, supported by rising poultry product demand and biosecurity awareness.

Asia Pacific: Holds the third-largest market with USD 0.17 billion in 2025, driven by increasing poultry consumption and vaccine adoption.

Latin America & Middle East & Africa: Moderate growth is projected, with 2025 valuations at USD 0.11 billion and USD 0.06 billion, respectively, supported by government initiatives to improve poultry health.

Competitive Landscape

The market is semi-fragmented, with dominant players including Zoetis Services LLC, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Elanco, Ceva, HIPRA, and Bioveta, a.s. These companies focus on product launches, strategic partnerships, and geographic expansion to maintain their leadership. Key industry developments include Bioveta launching an inactivated vaccine against bacterial pasteurellosis (July 2025) and Virbac acquiring Globion (Oct 2023) to expand its India operations.

Conclusion

The global poultry vaccines market is set to grow from USD 1.32 billion in 2025 to USD 1.38 billion in 2026, reaching USD 2.38 billion by 2034 at a CAGR of 6.99%. Market expansion is fueled by rising poultry consumption, outbreaks of infectious diseases, government vaccination campaigns, and innovations such as in-ovo vaccination. While challenges like vaccine failures and cold chain limitations persist, opportunities in technological advancement, product launches, and strategic government initiatives are likely to sustain market growth. Leading companies' strong R&D focus and portfolio diversification further consolidate their market position.

Segmentation By Technology

  • Inactivated
  • Live Attenuated
  • Recombinant
  • Others

By Disease Type

  • Viral Diseases
    • Avian Influenza
    • Newcastle Disease
    • Marek's Disease
    • Others
  • Bacterial Diseases
    • Salmonellosis
    • Mycoplasmosis
    • Others
  • Parasitic Diseases

By Route of Administration

  • Parenteral
  • Intranasal
  • Others

By Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

By Region

  • North America (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country)
    • U.S.
    • Canada
  • Europe (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
    • GCC
    • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends
  • 3.5. Market Challenges

4. Key Insights

  • 4.1. Overview of Poultry Diseases by Key Countries, By Key Countries/ Region, 2025
  • 4.2. Regulatory Scenario by Key Countries/ Region, 2025
  • 4.3. Overview of Vaccination for Poultry Diseases
  • 4.4. New Technology Launches, By Key Players
  • 4.5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)

5. Global Poultry Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Technology
    • 5.1.1. Inactivated
    • 5.1.2. Live Attenuated
    • 5.1.3. Recombinant
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Disease Type
    • 5.2.1. Viral Diseases
      • 5.2.1.1. Avian Influenza
      • 5.2.1.2. Newcastle Disease
      • 5.2.1.3. Marek's Disease
      • 5.2.1.4. Others
    • 5.2.2. Bacterial Diseases
      • 5.2.2.1. Salmonellosis
      • 5.2.2.2. Mycoplasmosis
      • 5.2.2.3. Others
    • 5.2.3. Parasitic Diseases
  • 5.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.3.1. Parenteral
    • 5.3.2. Intranasal
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.4.1. Veterinary Hospitals
    • 5.4.2. Veterinary Clinics
    • 5.4.3. Pharmacies & Drug Stores
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Poultry Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Technology
    • 6.1.1. Inactivated
    • 6.1.2. Live Attenuated
    • 6.1.3. Recombinant
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Disease Type
    • 6.2.1. Poultry Influenza
    • 6.2.2. Lyme Disease
    • 6.2.3. Rabies
    • 6.2.4. Leptospirosis
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.3.1. Oral
    • 6.3.2. Parenteral
    • 6.3.3. Intranasal
  • 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.4.1. Veterinary Hospitals
    • 6.4.2. Veterinary Clinics
    • 6.4.3. Pharmacies & Drug Stores
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Poultry Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Technology
    • 7.1.1. Inactivated
    • 7.1.2. Live Attenuated
    • 7.1.3. Recombinant
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Disease Type
    • 7.2.1. Viral Diseases
      • 7.2.1.1. Avian Influenza
      • 7.2.1.2. Newcastle Disease
      • 7.2.1.3. Marek's Disease
      • 7.2.1.4. Others
    • 7.2.2. Bacterial Diseases
      • 7.2.2.1. Salmonellosis
      • 7.2.2.2. Mycoplasmosis
      • 7.2.2.3. Others
    • 7.2.3. Parasitic Diseases
  • 7.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.3.1. Parenteral
    • 7.3.2. Intranasal
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.4.1. Veterinary Hospitals
    • 7.4.2. Veterinary Clinics
    • 7.4.3. Pharmacies & Drug Stores
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.5.1. Germany
    • 7.5.2. U.K.
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Poultry Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Technology
    • 8.1.1. Inactivated
    • 8.1.2. Live Attenuated
    • 8.1.3. Recombinant
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Disease Type
    • 8.2.1. Viral Diseases
      • 8.2.1.1. Avian Influenza
      • 8.2.1.2. Newcastle Disease
      • 8.2.1.3. Marek's Disease
      • 8.2.1.4. Others
    • 8.2.2. Bacterial Diseases
      • 8.2.2.1. Salmonellosis
      • 8.2.2.2. Mycoplasmosis
      • 8.2.2.3. Others
    • 8.2.3. Parasitic Diseases
  • 8.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.3.1. Parenteral
    • 8.3.2. Intranasal
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.4.1. Veterinary Hospitals
    • 8.4.2. Veterinary Clinics
    • 8.4.3. Pharmacies & Drug Stores
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.5.1. China
    • 8.5.2. Japan
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Poultry Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Technology
    • 9.1.1. Inactivated
    • 9.1.2. Live Attenuated
    • 9.1.3. Recombinant
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Disease Type
    • 9.2.1. Viral Diseases
      • 9.2.1.1. Avian Influenza
      • 9.2.1.2. Newcastle Disease
      • 9.2.1.3. Marek's Disease
      • 9.2.1.4. Others
    • 9.2.2. Bacterial Diseases
      • 9.2.2.1. Salmonellosis
      • 9.2.2.2. Mycoplasmosis
      • 9.2.2.3. Others
    • 9.2.3. Parasitic Diseases
  • 9.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.3.1. Parenteral
    • 9.3.2. Intranasal
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.4.1. Veterinary Hospitals
    • 9.4.2. Veterinary Clinics
    • 9.4.3. Pharmacies & Drug Stores
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Poultry Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Technology
    • 10.1.1. Inactivated
    • 10.1.2. Live Attenuated
    • 10.1.3. Recombinant
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Disease Type
    • 10.2.1. Viral Diseases
      • 10.2.1.1. Avian Influenza
      • 10.2.1.2. Newcastle Disease
      • 10.2.1.3. Marek's Disease
      • 10.2.1.4. Others
    • 10.2.2. Bacterial Diseases
      • 10.2.2.1. Salmonellosis
      • 10.2.2.2. Mycoplasmosis
      • 10.2.2.3. Others
    • 10.2.3. Parasitic Diseases
  • 10.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.3.1. Parenteral
    • 10.3.2. Intranasal
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.4.1. Veterinary Hospitals
    • 10.4.2. Veterinary Clinics
    • 10.4.3. Pharmacies & Drug Stores
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Technology, SWOT analysis, Recent developments, strategies, financials (based on availability))
    • 11.2.1. Elanco
    • 11.2.2. Boehringer Ingelheim International GmbH
    • 11.2.3. Virbac
    • 11.2.4. Merck & Co., Inc.
    • 11.2.5. Zoetis Services LLC
    • 11.2.6. Ceva
    • 11.2.7. Bioveta, a.s.
    • 11.2.8. Indian Immunologicals Ltd.
    • 11.2.9. HIPRA

List of Tables

  • Table 1: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 2: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 3: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2021-2034
  • Table 4: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2021-2034
  • Table 5: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 6: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 7: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 8: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 9: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 10: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2021-2034
  • Table 11: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2021-2034
  • Table 12: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 13: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 14: North America Poultry Vaccines Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 15: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 16: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 17: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2021-2034
  • Table 18: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2021-2034
  • Table 19: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 20: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 21: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 22: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 23: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 24: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2021-2034
  • Table 25: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2021-2034
  • Table 26: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 27: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 28: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 29: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 30: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 31: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2021-2034
  • Table 32: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2021-2034
  • Table 33: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 34: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 35: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 36: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 37: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 38: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2021-2034
  • Table 39: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2021-2034
  • Table 40: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 41: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 42: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Poultry Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Poultry Vaccines Market Value Share (%), by Technology, 2025 & 2034
  • Figure 3: Global Poultry Vaccines Market Value Share (%), by Disease Type, 2025 & 2034
  • Figure 4: Global Poultry Vaccines Market Value Share (%), by Route of Administration, 2025 & 2034
  • Figure 5: Global Poultry Vaccines Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 6: Global Poultry Vaccines Market Value Share (%), by Region, 2025 & 2034
  • Figure 7: North America Poultry Vaccines Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 8: North America Poultry Vaccines Market Value Share (%), by Technology, 2025
  • Figure 9: North America Poultry Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
  • Figure 10: North America Poultry Vaccines Market Value Share (%), by Disease Type, 2025
  • Figure 11: North America Poultry Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 12: North America Poultry Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 13: North America Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 14: North America Poultry Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 15: North America Poultry Vaccines Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Poultry Vaccines Market Value Share (%), By Country, 2025
  • Figure 17: Europe Poultry Vaccines Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 18: Europe Poultry Vaccines Market Value Share (%), by Technology, 2025
  • Figure 19: Europe Poultry Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
  • Figure 20: Europe Poultry Vaccines Market Value Share (%), by Disease Type, 2025
  • Figure 21: Europe Poultry Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 22: Europe Poultry Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 23: Europe Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 24: Europe Poultry Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 25: Europe Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Poultry Vaccines Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 28: Asia Pacific Poultry Vaccines Market Value Share (%), by Technology, 2025
  • Figure 29: Asia Pacific Poultry Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
  • Figure 30: Asia Pacific Poultry Vaccines Market Value Share (%), by Disease Type, 2025
  • Figure 31: Asia Pacific Poultry Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 32: Asia Pacific Poultry Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 33: Asia Pacific Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 34: Asia Pacific Poultry Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 35: Asia Pacific Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Poultry Vaccines Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 38: Latin America Poultry Vaccines Market Value Share (%), by Technology, 2025
  • Figure 39: Latin America Poultry Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
  • Figure 40: Latin America Poultry Vaccines Market Value Share (%), by Disease Type, 2025
  • Figure 41: Latin America Poultry Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 42: Latin America Poultry Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 43: Latin America Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 44: Latin America Poultry Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 45: Latin America Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 48: Middle East & Africa Poultry Vaccines Market Value Share (%), by Technology, 2025
  • Figure 49: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
  • Figure 50: Middle East & Africa Poultry Vaccines Market Value Share (%), by Disease Type, 2025
  • Figure 51: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 52: Middle East & Africa Poultry Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 53: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 54: Middle East & Africa Poultry Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 55: Middle East & Africa Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Poultry Vaccines Market Share (%), By Company, 2025